retatrutide type 2 diabetes phase 2 trial Reta clinical data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in 3 trials for metabolic health — targeting GLP-1, GIP retatrutide type 2 diabetes trial
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15

























![Seize the Spotlight (Promo Pack) [Streets of New Capenna Commander Promos] Vehicle Island](https://cdn.shopify.com/s/files/1/0670/1927/6566/products/76c4c7dd-e354-509f-b26e-c3fd1875a9b8_befb3af8-9def-4ee6-85c9-9cc88b81b558.jpg?v=1697058032)